Diabetes

By Jonah Comstock September 13, 2017
Mountain View, California-based Livongo Health, the chronic condition management technology company founded by former Allscripts CEO Glen Tullman, has acquired Diabeto, a diabetes management company based in Piscataway, New Jersey in the US and Maharashtra in India. The terms of the acquisition were not disclosed. Though it was founded in 2012, Diabeto really hit the scene in 2015 with an...
By Jeff Lagasse August 28, 2017
NxStage Medical, a medical technology outfit focused on advancing renal care, has received clearance from the FDA for its System One, which allows for solo home hemodialysis, without a care partner, during waking hours.   The company received its first clearance for home hemodialysis from the FDA in 2005, and in 2014 was cleared for home nocturnal hemodialysis. Since then, NxStage estimates that...
By Jeff Lagasse August 21, 2017
IBM and JDRF, a global organization funding Type 1 diabetes research, are joining forces. The collaboration will develop machine learning methods and use them to analyze years of Type 1 research data to pinpoint the factors that can contribute to the onset of the condition in children.   Type 1 diabetes  -- T1D for short -- affects about 1.25 million Americans, and to date does not have a cure....
By Jeff Lagasse August 16, 2017
Diabetes therapy management software company Glytec has just secured its fourth FDA clearance, adding a slew of capabilities to its Glucommander product, the core of its eGlycemic Management System.   This latest FDA clearance incorporates some of the product enhancements that have been suggested by the company’s user community, including a titration module designed expressly for inpatients...
By Jeff Lagasse July 17, 2017
Abbott and Bigfoot Biomedical have entered into an agreement to develop and commercialize diabetes management systems, integrating Abbott's FreeStyle Libre glucose sensing technology with Bigfoot's insulin delivery solutions.    Under the agreement, Abbott will supply glucose measurement sensors for all of Bigfoot's insulin delivery systems in the U.S. as the exclusive sensors for those systems...
By Jeff Lagasse July 17, 2017
Novo Nordisk and Glooko are working together to help people manage diabetes from their phones. The companies have partnered on the Cornerstones4Care Powered by Glooko, an app melding Novo Nordisk’s knowledge of diabetes and personalized patient support with Glooko’s digital platform and data analytics know-how. The idea behind the app is to provide, for people with diabetes, a means of measuring...
By Jonah Comstock June 29, 2017
While it may or may not be working on a secret glucose wearable, Apple has definitely upgraded its HealthKit app framework to provide more tracking options for people with diabetes. In addition, the company made some other upgrades to both the HealthKit and ResearchKit frameworks. Apple engineers shared these updates at WWDC earlier this month. “Our users love using Apple products to help manage...
By Jonah Comstock June 7, 2017
At long last, Dexcom's Share app, which allows users to view and share data from their G5 continuous glucose monitors, will be available for Android users. The Android app just now received FDA clearance, and the company will roll out the app this month. The launch is a long time coming: iOS users have had access to the app since 2015. “Providing Android users with access to the Dexcom G5 Mobile...
By Heather Mack June 1, 2017
Digital diabetes management company Glooko and device maker Dexcom have expanded their partnership, effectively creating on-demand access to continuous glucose monitor data for both physicians and patients who use the two companies’ products. Glooko and Dexcom began working together in June 2015, when Glooko first began integrating CGMs and insulin pumps into its platform. But for the past two...
By Jonah Comstock May 12, 2017
A new partnership in the diabetes space could bring the promise of an artificial pancreas closer to reality. Senseonics, a Germantown, Maryland company working on a pill-sized, implantable continuous glucose monitor that can last 90 days without needing replacement, will work with digital, personalized medicine company TypeZero Technologies on a project to integrate readings from Senseonics...

Editor's Pick